Educating Providers and Patients About Insulin Biosimilars

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/07/59/8b/07598b02-138a-1e92-767a-a6ad123b0f45/mza_3116404523087549397.jpg/600x600bb.jpg

Diabetes Discourse

ReachMD

202 episodes

1 month ago

As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because when it comes to diabetes, glucose control is just the beginning.

Science

Medicine

RSS

All content for Diabetes Discourse is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Educating Providers and Patients About Insulin Biosimilars

Diabetes Discourse

2 years ago

Educating Providers and Patients About Insulin Biosimilars

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Elizabeth Cook, PharmD, AE-C, BCACP, CDCES

With a shortage of insulin products in the United States, our diabetic patients are left without lifesaving medications, making this a prominent barrier in clinical practice. However, insulin biosimilars may offer more accessibility and affordability, but what do we know about them? Join Dr. Mary Katherine Cheeley as she speaks with Dr. Lizzie Cook, Clinical Pharmacist at Robert J. Dole Veteran Affairs Medical Center in Wichita, Kansas.